Who is sponsoring NCT04753853?

NCT04753853 is sponsored by Istituto Ortopedico Rizzoli.

What drugs are being tested in NCT04753853?

Interventions in NCT04753853: Stromal Vascular Fraction injection.

What condition does NCT04753853 study?

NCT04753853 studies Patellar Tendinitis, Tendinopathy, Patellar Tendinopathy.

Is NCT04753853 still recruiting?

NCT04753853 is currently completed. Last updated 12 September 2025.

Last reviewed 2025-09-12 · How we verify

NCT04753853

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stromal Vascular Fraction (SVF) Injection in the Treatment of Patellar Tendinopathy

Completed NA Last updated 12 September 2025

What this trial tests

NA trial testing Stromal Vascular Fraction injection in Patellar Tendinitis in 30 participants. Completed in 5 May 2025.

Timeline

1 July 2021

Primary endpoint
10 February 2022

5 May 2025

Quick facts

Lead sponsor	Istituto Ortopedico Rizzoli
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 July 2021
Primary completion	10 February 2022
Estimated completion	5 May 2025
Sites	1 location across Italy

Drugs / interventions tested

Stromal Vascular Fraction injection

Conditions studied

Patellar Tendinitis — all drugs for Patellar Tendinitis →
Tendinopathy — all drugs for Tendinopathy →
Patellar Tendinopathy — all drugs for Patellar Tendinopathy →

Sponsor

Istituto Ortopedico Rizzoli — full company profile →

Who can join

Adults 18 to 60, any sex, with Patellar Tendinitis or Tendinopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is the evaluation of clinical and radiological results after the treatment of patellar tendinopathy through the injection of autologous ultrasound-guided, intra- and peri-tendon stromal vascular fraction.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

State-of the-art and future perspective in co-culture systems for tendon engineering.
Guillaumin S, Rossoni A, Zeugolis D. · · 2025 · cited 2× · PMID 40130022 · DOI 10.1016/j.bbiosy.2025.100110

Verify or expand the search:

Other Istituto Ortopedico Rizzoli trials

Trials by the same sponsor.

NCT07590882 — Evaluation of Return to Sports Activity After Periacetabular Osteotomy: An Observational Study · enrolling by invitation
NCT07021222 — Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot (DARE-DiaF · NA · recruiting
NCT07360964 — Clear Cell Chondrosarcoma in Italy · NA · active not recruiting
NCT07140367 — "Transarterial Microembolization (TAME) in Inflammatory Knee Pathology" · recruiting
NCT07102875 — Ready to Sail 2: A Pilot Study of Sail-Assisted Telerehabilitation in Rare Skeletal Diseases · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04753853 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istituto Ortopedico Rizzoli
Last refreshed: 12 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04753853.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing